MedPath

The treatment of brain-machine interface for post-stroke upper limb paralysis

Not Applicable
Recruiting
Conditions
A patient with upper limb paralysis after a first stroke
stroke
Registration Number
JPRN-jRCTs042230092
Lead Sponsor
eki Yoshino
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

(1) Patients for whom 10 days or more have passed since the onset of stroke
(2) Age 20 years or older
(3) Adult patients with upper limb paralysis after their first stroke who meet the following criteria:
(3)-1 Patients who have not lost deep sensation in the paralyzed finger
(3)-2 Patients whose range of motion in passive extension of the MP joint of the paralyzed finger is -10 degrees or more
(3)-3 Patients with severe to moderate motor function of the paralyzed hand (e.g. 40 points or less on the Fugl-Meyer Assessment)
(4) Patients who can give their own written consent. If the subject has sufficient ability to consent, but has difficulty writing due to paralysis or aphasia, confirm the subject's consent and obtain written consent from a surrogate writer.

Exclusion Criteria

(1) Patients for whom it is difficult to perform BMI. A specific example is below.
(1)-1 Serious heart disease
(1)-2 Uncontrolled hypertension
(1)-3 Complications of pulmonary embolism, acute cor pulmonale, or severe pulmonary hypertension within 90 days before the start of the study
(1)-4 Complications of severe liver/kidney dysfunction
(1)-5 Complications of serious orthopedic disease that impede movement
(1)-6 Severe cognitive impairment, comorbidity of severe mental illness
(1)-7 Patients who cannot wear a headset or electric orthosis
(1)-8Persons using a pacemaker or implantable defibrillator
(1)-9 People who have significant pain at the attachment site
(1)-10 People with febrile illness
(1)-11 People with skin sensitivity disorder
(1)-12 People who have difficulty attaching electrodes due to active skin disease (infectious diseases), etc.
(1)-13 Persons with malignant tumor or tuberculosis disease
(1)-14 People with severe spasticity or contracture
(1)-15 Pregnant women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath